Guangdong, China

Qingguo Ruan

This inventor holds 1 USPTO granted patent. Top assignees: Shenzhen Institutes of Advanced Technology, University of Pennsylvania. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Qingguo Ruan: Innovator in Autoimmune Psoriasis Treatment

Introduction

Qingguo Ruan is a notable inventor based in Guangdong, China. He has made significant contributions to the field of medical science, particularly in the treatment of autoimmune diseases. His innovative work focuses on the development of specific therapeutic agents that target inflammatory pathways.

Latest Patents

Qingguo Ruan holds a patent for a groundbreaking invention titled "C-Rel-specific siRNA and its use for preventing and treating autoimmune psoriasis." This invention provides a c-Rel-specific small interfering RNA (siRNA) that is utilized to inhibit c-Rel biosynthesis. The patent outlines how these siRNAs can prevent and treat autoimmune psoriasis by targeting inflammatory factors associated with the IL-23/IL-17A inflammatory axis. He has 1 patent registered under his name.

Career Highlights

Throughout his career, Qingguo Ruan has worked with prestigious institutions, including the Shenzhen Institutes of Advanced Technology and the University of Pennsylvania. His research has focused on innovative approaches to combat autoimmune conditions, showcasing his dedication to advancing medical science.

Collaborations

Qingguo Ruan has collaborated with esteemed colleagues such as Youhai H Chen and Tingting Fan. These partnerships have contributed to the development of his innovative research and patents.

Conclusion

Qingguo Ruan's work in developing c-Rel-specific siRNA represents a significant advancement in the treatment of autoimmune psoriasis. His contributions to medical science highlight the importance of innovation in addressing complex health issues.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…